Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Intelgenx Technologies Corp (IGXT)

Intelgenx Technologies Corp (IGXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 29,168
  • Shares Outstanding, K 174,658
  • Annual Sales, $ 1,040 K
  • Annual Income, $ -9,930 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 2.47
  • Price/Sales 29.17
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $-0.02 on 05/15/24
  • Next Earnings Date 05/28/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1396 +19.63%
on 04/23/24
0.1900 -12.11%
on 05/07/24
-0.0130 (-7.22%)
since 04/16/24
3-Month
0.1310 +27.48%
on 02/22/24
0.1900 -12.11%
on 05/07/24
+0.0170 (+11.33%)
since 02/16/24
52-Week
0.0900 +85.56%
on 10/31/23
0.2237 -25.35%
on 06/23/23
+0.0255 (+18.02%)
since 05/16/23

Most Recent Stories

More News
CHANGES TO BOARD OF DIRECTORS OF GEEKCO

/CNW/ - Geekco Technologies Corporation (the "Corporation" or "Geekco") (TSXV: GKO) (OTCQB: GKOTF) is pleased to announce the appointments of André Godin and...

GKOTF : 0.0243 (-55.41%)
GKO.VN : 0.045 (-10.00%)
IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx Announces Completion of Share Issuance in Payment of Principal and Interest on Debentures

SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

SAINT LAURENT, Quebec, March 24, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)
First Patient Dosed in IntelGenx’s Resumed ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease

SAINT LAURENT, Quebec, Jan. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”), a leader in...

IGXT : 0.1670 (-3.75%)
IGX.TO : 0.2400 (+17.07%)

Business Summary

IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The Company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastro-intestinal tract. IntelGenx...

See More

Key Turning Points

3rd Resistance Point 0.1811
2nd Resistance Point 0.1752
1st Resistance Point 0.1711
Last Price 0.1670
1st Support Level 0.1611
2nd Support Level 0.1552
3rd Support Level 0.1511

See More

52-Week High 0.2237
Fibonacci 61.8% 0.1726
Last Price 0.1670
Fibonacci 50% 0.1569
Fibonacci 38.2% 0.1411
52-Week Low 0.0900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar